Literature DB >> 27414157

Addition of RAS Mutation Status May Strengthen the Predictive Model for Progression of Indeterminate Pulmonary Nodules.

Yoshihiro Mise1, Jean-Nicolas Vauthey, Scott Kopetz.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27414157      PMCID： PMC4948950          DOI： 10.1097/SLA.0000000000001103

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  9 in total

1.  Simultaneous lung resection via a transdiaphragmatic approach in patients undergoing liver resection for synchronous liver and lung metastases.

Authors:  Yoshihiro Mise; Reza J Mehran; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  Surgery       Date:  2014-06-20       Impact factor: 3.982

2.  RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.

Authors:  Jean-Nicolas Vauthey; Giuseppe Zimmitti; Scott E Kopetz; Junichi Shindoh; Su S Chen; Andreas Andreou; Steven A Curley; Thomas A Aloia; Dipen M Maru
Journal:  Ann Surg       Date:  2013-10       Impact factor: 12.969

3.  KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancer.

Authors:  Jeanne Tie; Lara Lipton; Jayesh Desai; Peter Gibbs; Robert N Jorissen; Michael Christie; Katharine J Drummond; Benjamin N J Thomson; Valery Usatoff; Peter M Evans; Adrian W Pick; Simon Knight; Peter W G Carne; Roger Berry; Adrian Polglase; Paul McMurrick; Qi Zhao; Dana Busam; Robert L Strausberg; Enric Domingo; Ian P M Tomlinson; Rachel Midgley; David Kerr; Oliver M Sieber
Journal:  Clin Cancer Res       Date:  2011-01-14       Impact factor: 12.531

4.  Indeterminate Pulmonary Nodules in Colorectal Cancer: Follow-up Guidelines Based on a Risk Predictive Model.

Authors:  Chang Hyun Kim; Jung Wook Huh; Hyeong Rok Kim; Young Jin Kim
Journal:  Ann Surg       Date:  2015-06       Impact factor: 12.969

5.  Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

Authors:  Wendy De Roock; Bart Claes; David Bernasconi; Jef De Schutter; Bart Biesmans; George Fountzilas; Konstantine T Kalogeras; Vassiliki Kotoula; Demetris Papamichael; Pierre Laurent-Puig; Frédérique Penault-Llorca; Philippe Rougier; Bruno Vincenzi; Daniele Santini; Giuseppe Tonini; Federico Cappuzzo; Milo Frattini; Francesca Molinari; Piercarlo Saletti; Sara De Dosso; Miriam Martini; Alberto Bardelli; Salvatore Siena; Andrea Sartore-Bianchi; Josep Tabernero; Teresa Macarulla; Frédéric Di Fiore; Alice Oden Gangloff; Fortunato Ciardiello; Per Pfeiffer; Camilla Qvortrup; Tine Plato Hansen; Eric Van Cutsem; Hubert Piessevaux; Diether Lambrechts; Mauro Delorenzi; Sabine Tejpar
Journal:  Lancet Oncol       Date:  2010-07-08       Impact factor: 41.316

6.  Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy?

Authors:  Antoine Brouquet; Melinda M Mortenson; Jean-Nicolas Vauthey; Miguel A Rodriguez-Bigas; Michael J Overman; George J Chang; Scott Kopetz; Christopher Garrett; Steven A Curley; Eddie K Abdalla
Journal:  J Am Coll Surg       Date:  2010-06       Impact factor: 6.113

7.  KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis.

Authors:  Paloma Cejas; Miriam López-Gómez; Cristina Aguayo; Rosario Madero; Javier de Castro Carpeño; Cristóbal Belda-Iniesta; Jorge Barriuso; Víctor Moreno García; Javier Larrauri; Rocío López; Enrique Casado; Manuel Gonzalez-Barón; Jaime Feliu
Journal:  PLoS One       Date:  2009-12-18       Impact factor: 3.240

Review 8.  Concordant KRAS mutations in primary and metastatic colorectal cancer tissue specimens: a meta-analysis and systematic review.

Authors:  Cheng-Bo Han; Fan Li; Jie-Tao Ma; Hua-Wei Zou
Journal:  Cancer Invest       Date:  2012-10-17       Impact factor: 2.176

9.  KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients.

Authors:  N Knijn; L J M Mekenkamp; M Klomp; M E Vink-Börger; J Tol; S Teerenstra; J W R Meijer; M Tebar; S Riemersma; J H J M van Krieken; C J A Punt; I D Nagtegaal
Journal:  Br J Cancer       Date:  2011-03-01       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.